Elagolix (Orilissa) for Endometriosis Pain.

American family physician · 2019 · vol. 100(8) , pp. 502–504 · PMID:31613570 · W2980459555
article OA: closed CC0 ⤵ 2 in-corpus citations
View on OpenAlex View on PubMed
AI-generated summary by claude@2026-06, 2026-06-09

Elagolix effectively reduced endometriosis pain in women but is costly and shares estrogen-lowering side effects with comparable treatments.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Elagolix can decrease pain in women with endometriosis, but it is expensive and has adverse effects similar to those of other medications that decrease estrogen levels.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Hydrocarbons, Fluorinated Pain Pyrimidines Adult Endometriosis Female Humans Hydrocarbons, Fluorinated Pain Pyrimidines

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (2)

Cited by (2)

Source provenance

europepmc
last seen: 2026-06-12T06:13:51.797165+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:22:29.487098+00:00
License: CC0 · commercial use OK